|
31
|
| 77 |
SEMA3A
|
|
decreases_activity of
|
angiogenesis
|
|
|
17569671
|
Amyotrophic lateral sclerosis
|
|
79
|
| 271 |
SEMA3A
|
|
decreases_activity of
|
angiogenesis
|
mediated by VEGF
|
|
18180379
|
Amyotrophic lateral sclerosis
|
|
237
|
| 982 |
VEGFA
|
|
increases_activity of
|
angiogenesis
|
|
|
9618543
|
Amyotrophic lateral sclerosis
|
|
312
|
| 1234 |
VEGFA
|
|
increases_activity of
|
angiogenesis
|
|
| 1236 |
PGF
|
|
increases_activity of
|
angiogenesis
|
|
|
15258583
|
Amyotrophic lateral sclerosis
|
|
607
|
| 3208 |
SEMA3A
|
|
decreases_activity of
|
angiogenesis
|
|
|
17099709
|
Amyotrophic lateral sclerosis
|
|
668
|
| 3562 |
Status epilepticus
|
|
affects_activity of
|
angiogenesis
|
in pilocarpine model
|
|
19320047
|
Status epilepticus
|
|
1,114
|
| 7157 |
P4HA1
|
|
increases_activity of
|
angiogenesis
|
|
| 7158 |
collagen fibril organization
|
|
increases_activity of
|
angiogenesis
|
|
|
18439917
|
Cardiovascular disease
|
|
2,124
|
| 17422 |
Nebivolol
|
|
increases_activity of
|
angiogenesis
|
|
|
16116070
|
Diabetes mellitus, type II
Insulin resistance
|
|
2,589
|
| 24437 |
ATM
|
|
affects_activity of
|
angiogenesis
|
|
|
20676049
|
Diabetes mellitus, type II
Ataxia-telangiectasia
Insulin resistance
|
|
2,814
|
| 26084 |
ADIPOQ
|
|
decreases_activity of
|
angiogenesis
|
|
| 26086 |
IL6
|
|
increases_activity of
|
angiogenesis
|
|
| 26087 |
TNF
|
|
increases_activity of
|
angiogenesis
|
|
| 129691 |
inflammatory response
|
|
increases_activity of
|
angiogenesis
|
|
|
21912508
|
Diabetes mellitus, type II
Cancer
Insulin resistance
Metabolic syndrome
|
|
4,456
|
| 44947 |
ABCG2-null
|
|
affects_activity of
|
angiogenesis
|
|
|
22116099
|
Cardiomyopathy, hypertrophic
|
|
5,172
|
| 50757 |
Epicatechin
|
|
increases_activity of
|
angiogenesis
|
in the hippocampus; of mice
|
|
23810791
|
Neurological
Alzheimer disease
|
|
5,299
|
| 51884 |
NT-PPARGC1A-a
|
|
increases_activity of
|
angiogenesis
|
in skeletal muscle
|
| 51889 |
NT-PPARGC1A-b
|
|
increases_activity of
|
angiogenesis
|
in skeletal muscle; in vivo
|
|
24505137
|
Diabetes mellitus, type II
Insulin resistance
|
|
5,304
|
| 52066 |
PPARGC1A-b
|
|
increases_activity of
|
angiogenesis
|
in skeletal muscle; if PPARGC1A-b is overexpressed in skeletal muscle
|
|
22174785
|
Diabetes mellitus, type II
Insulin resistance
|
|
5,305
|
| 51823 |
exercise
|
|
increases_activity of
|
angiogenesis
|
in skeletal muscle; via PPARGC1A
|
| 52073 |
PPARGC1A
|
|
affects_activity of
|
angiogenesis
|
in skeletal muscle; after exercise
|
| 52107 |
exercise
|
|
increases_activity of
|
angiogenesis
|
in skeletal muscle; via ESRRA
|
|
19966219
|
Diabetes mellitus, type II
Insulin resistance
|
|
5,314
|
| 52487 |
PPARGC1A
|
|
increases_activity of
|
angiogenesis
|
in skeletal muscle
|
| 52488 |
ESRRA
|
|
affects_activity of
|
angiogenesis
|
in skeletal muscle
|
|
18288196
|
Diabetes mellitus, type II
Insulin resistance
|
|
5,397
|
| 52649 |
HIF1A
|
|
increases_activity of
|
angiogenesis
|
|
| 52650 |
EPAS1
|
|
increases_activity of
|
angiogenesis
|
|
|
21106753
|
Diabetes mellitus, type II
Insulin resistance
|
|
5,420
|
| 52926 |
Amyloid beta peptide (40)
|
|
decreases_activity of
|
angiogenesis
|
via ALDH2 inhibition
|
| 52927 |
ALDH2
|
|
increases_activity of
|
angiogenesis
|
|
|
23447675
|
Diabetes mellitus, type II
Insulin resistance
|
|
5,936
|
| 56021 |
AGGF1
|
|
increases_activity of
|
angiogenesis
|
|
|
14961121
|
Klippel-Trenaunay-Weber syndrome
|
|
5,938
|
| 56030 |
AGGF1
|
|
increases_activity of
|
angiogenesis
|
in hepatocellular carcinoma (HCC) tumor tissue
|
|
25796501
|
Hepatocellular carcinoma
|
|
6,211
|
| 58860 |
Ellagic acid
|
|
decreases_activity of
|
angiogenesis
|
in ECV304 cells; hypoxia-induced angiogenesis,
via suppression of HDAC6.
|
|
25060902
|
Cancer
Metabolic
|
|
6,271
|
| 58632 |
HDAC inhibitor
|
|
decreases_activity of
|
angiogenesis
|
|
|
21362133
|
Cancer
|
|
6,456
|
| 61386 |
Metformin
|
|
decreases_activity of
|
angiogenesis
|
in tumors
|
| 61389 |
VEGFA
|
|
increases_activity of
|
angiogenesis
|
|
| 61390 |
SERPINE1
|
|
increases_activity of
|
angiogenesis
|
|
| 61391 |
angiogenesis
|
|
increases_activity of
|
Cancer
|
|
|
22117616
|
Diabetes mellitus, type II
Cancer
Insulin resistance
|
|
6,646
|
| 64113 |
Lactate
|
|
increases_activity of
|
angiogenesis
|
|
|
25672512
|
Cancer
|
|
6,716
|
| 64861 |
FES
|
|
affects_activity of
|
angiogenesis
|
|
|
21159660
|
Cancer
|
|
6,730
|
| 65172 |
SCUBE3
|
|
increases_activity of
|
angiogenesis
|
by activating TGFbeta signaling
|
|
23420440
|
Lung cancer
Cancer
|
|
7,226
|
| 71139 |
PLPP3
|
|
increases_activity of
|
angiogenesis
|
|
|
|
Coronary artery disease
|
|
7,424
|
| 72986 |
Lysophosphatidic acid
|
|
increases_activity of
|
angiogenesis
|
|
|
26594106
|
Diabetes mellitus, type II
Insulin resistance
Atherosclerosis
|
|
7,591
|
| 76407 |
Prostanoid
|
|
affects_activity of
|
angiogenesis
|
|
| 76414 |
Prostaglandin E2
|
|
increases_activity of
|
angiogenesis
|
|
|
15896353
|
Diabetes mellitus, type II
Insulin resistance
Atherosclerosis
|
|
7,665
|
| 76719 |
DICER1
|
|
affects_activity of
|
angiogenesis
|
|
| 76724 |
VEGFA
|
|
increases_activity of
|
angiogenesis
|
|
| 76725 |
FLT1
|
|
increases_activity of
|
angiogenesis
|
|
| 76727 |
KDR
|
|
increases_activity of
|
angiogenesis
|
|
| 76728 |
mir-126
|
|
increases_activity of
|
angiogenesis
|
|
| 76730 |
mir-221
|
|
affects_activity of
|
angiogenesis
|
|
| 76731 |
mir-222
|
|
decreases_activity of
|
angiogenesis
|
|
| 76736 |
angiogenesis
|
|
increases_activity of
|
placenta development
|
|
| 76737 |
mir-17
|
|
decreases_activity of
|
angiogenesis
|
|
| 76738 |
mir-20a
|
|
affects_activity of
|
angiogenesis
|
|
| 76739 |
mir-20b
|
|
affects_activity of
|
angiogenesis
|
|
| 76740 |
mir-92a
|
|
decreases_activity of
|
angiogenesis
|
|
| 76744 |
mir-34a
|
|
affects_activity of
|
angiogenesis
|
|
| 76748 |
mir-210
|
|
affects_activity of
|
angiogenesis
|
|
| 76749 |
mir-155
|
|
affects_activity of
|
angiogenesis
|
|
| 76750 |
mir-378a-5p
|
|
affects_activity of
|
angiogenesis
|
|
| 76751 |
mir-16
|
|
affects_activity of
|
angiogenesis
|
|
| 76775 |
mir-125b-1-3p
|
|
affects_activity of
|
angiogenesis
|
|
| 76806 |
mir-21
|
|
affects_activity of
|
angiogenesis
|
|
| 76808 |
mir-424
|
|
affects_activity of
|
angiogenesis
|
|
| 76815 |
mir-132
|
|
increases_activity of
|
angiogenesis
|
|
| 76818 |
mir-29a
|
|
increases_activity of
|
angiogenesis
|
|
|
26550492
|
Gestational diabetes mellitus
|
CIDeRplus